Table 2 Patient baseline characteristics per group in the study on management of osteoarthritis with a standardized evaluation tool (first motivating example)
Characteristics | Control | Standardized tool | p | SDiff (%) |
|---|---|---|---|---|
n 0=1495 | n 1=1462 | |||
mean (standard deviation) | mean (standard deviation) | |||
Duration of symptoms (months) | 68.0 (69.8) | 70.9 (75.0) | 0.2737 | 4.03 |
Age (years) | 67.2 (9.7) | 66.4 (10.0) | 0.0344 | 7.81 |
BMI (kg.m −2) | 27.8 (4.9) | 27.7 (4.7) | 0.3824 | 3.14 |
Patient global assessment (0-100) | 61.1 (18.2) | 56.7 (17.4) | < 0.0001 | 24.44 |
Pain evaluation VAS (0-100) | 59.4 (16.0) | 55.3 (15.1) | < 0.0001 | 26.32 |
WOMAC function score (0-100) | 45.5 (16.3) | 43.8 (16.0) | 0.0050 | 10.32 |
n (%) | n (%) | |||
Osteoarthritis in other joints | 1366 (91.4) | 1311 (89.7) | 0.1297 | 5.81 |
Prior treatment | ||||
IA treatment | 434 (29.0) | 432 (29.6) | 0.7877 | 1.14 |
NSAIDs | 955 (63.9) | 958 (65.5) | 0.3689 | 3.45 |
SYSADOA | 617 (41.3) | 605 (41.4) | 0.9810 | 0.22 |
Male | 424 (28.4) | 459 (31.4) | 0.0782 | 6.65 |
Kellgren and Lawrence grade | 0.2594 | |||
III | 724 (48.4) | 677 (46.3) | 4.25 | |
IV | 516 (34.5) | 547 (37.4) | 6.02 |